Richard A. Young, Director at Syros Pharmaceuticals, Inc. (SYRS), sold 11,980 shares at $12.59 ($151K) on 2020-08-17, disclosed to the SEC on 2020-08-19.
Open-market sale of $151k SYRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.59 | 5,990 | $75K | 50.0% |
| 2 | $12.59 | 5,990 | $75K | 50.0% |
| Total | $12.59 avg | 11,980 | $151K | 100% |
| Filing → |
| OMGA | SELL | 2023-06-05 | $40K | — | Filing → |
| OMGA | SELL | 2023-05-03 | $40K | — | Filing → |
| OMGA | SELL | 2023-04-10 | $40K | — | Filing → |